Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Financial Statements Details - Outstanding Securities Considered Anti-Dilutive (Details)

v3.23.1
Condensed Consolidated Financial Statements Details - Outstanding Securities Considered Anti-Dilutive (Details) - shares
shares in Thousands
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Antidilutive Securities Excluded From Computation Of Earnings Per Share    
Antidilutive securities excluded from computation of net loss per share (in shares) 6,557 5,706
Convertible preferred stock    
Antidilutive Securities Excluded From Computation Of Earnings Per Share    
Antidilutive securities excluded from computation of net loss per share (in shares) 5,003 5,003
Stock Options    
Antidilutive Securities Excluded From Computation Of Earnings Per Share    
Antidilutive securities excluded from computation of net loss per share (in shares) 1,548 697
Warrants for common stock    
Antidilutive Securities Excluded From Computation Of Earnings Per Share    
Antidilutive securities excluded from computation of net loss per share (in shares) 6 6